- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: SB-497115-GR 12.5mg matching placebo
Total 20 results
-
GlaxoSmithKlineCompletedChronic Idiopathic Thrombocytopenic Purpura | Purpura, Thrombocytopenic, IdiopathicJapan
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedAcute Myelogenous Leukemia (AML)United States
-
Weill Medical College of Cornell UniversityNovartisCompletedImmune Thrombocytopenia | Platelet DisorderUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic Cell Transplantation Recipient | Bone Marrow Transplantation Recipient | Cord Blood Transplant RecipientUnited States
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopenic, Idiopathic | Idiopathic Thrombocytopenic PurpuraJapan
-
GlaxoSmithKlineCompletedHepatitis C, ChronicJapan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Thrombocytopenia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Novartis PharmaceuticalsCompletedPurpura, Thrombocytopaenic, IdiopathicUnited Kingdom, Hong Kong, United States, Germany, Italy, Netherlands, Spain, Taiwan, Thailand, Canada, Denmark, Pakistan, Romania, Slovenia, Russian Federation, Slovakia, Sweden, Poland, China, New Zealand, Ukraine, Australia, Austria and more
-
GlaxoSmithKlineCompletedAtherosclerosisNetherlands, Belgium, Germany, Czechia, France, Austria, Spain, Norway, Poland, Denmark, Switzerland
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedAnemia | Chronic Myelomonocytic Leukemia | Adult Myelodysplastic SyndromeUnited States
-
Suzhou Kintor Pharmaceutical Inc,CompletedTo Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic AlopeciaAlopecia | Male Pattern Hair LossUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
Ingrid Pabinger, MDGlaxoSmithKlineCompletedIdiopathic Thrombocytopenic Purpura
-
AstraZenecaCompletedSaxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseDiabetes Mellitus, Type 2United States, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
AstraZenecaCompleted
-
Praxis Precision MedicinesRecruitingSCN2A Encephalopathy | SCN8A EncephalopathyUnited States, Spain
-
AstraZenecaBristol-Myers SquibbCompletedDiabetes Mellitus, Type 2United States, Mexico, Canada, United Kingdom, India, Belgium, Taiwan
-
Vanderbilt UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedEnd Stage Renal Failure on Dialysis | Complication of HemodialysisUnited States
-
AstraZenecaCompletedType 2 Diabetes Mellitus, CKD and AlbuminuriaUnited States, Spain, Canada, Korea, Republic of, Mexico, Japan, Taiwan, Australia, South Africa
-
Boehringer IngelheimPfizerCompleted